ALTG 06/003 NITRO
A phase III, multi-centre randomised trial of adding nitroglycerin to first line chemotherapy for advanced non-small cell lung cancer.
The trial opened in May 2009 with recruitment closing in April 2014, with 372 patients randomised from 29 active sites. Follow-up has been completed and all sites are to be closed by December. The study results were presented at ESMO 2014 and ALLC 2014 and the final results have been submitted for publication.
Study Chair: Andrew Davidson
CTC Trial Coordinator: Nick Muljadi